Your browser doesn't support javascript.
loading
Agrimol B inhibits colon carcinoma progression by blocking mitochondrial function through the PGC-1α/NRF1/TFAM signaling pathway.
Xiang, Dongyang; Yang, Wenjuan; Fang, Zihan; Mao, Jialei; Yan, Qiuying; Li, Liu; Tan, Jiani; Yu, Chengtao; Qian, Jun; Tang, Dongxin; Pan, Xiaoting; Cheng, Haibo; Sun, Dongdong.
Afiliación
  • Xiang D; College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
  • Yang W; Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing, China.
  • Fang Z; Oncology Department, Kunshan Hospital Affiliated to Nanjing University of Chinese Medicine, Kunshan, China.
  • Mao J; Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing, China.
  • Yan Q; Oncology Department, Kunshan Hospital Affiliated to Nanjing University of Chinese Medicine, Kunshan, China.
  • Li L; Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing, China.
  • Tan J; Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing, China.
  • Yu C; The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, China.
  • Qian J; Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing, China.
  • Tang D; The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, China.
  • Pan X; Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing, China.
  • Cheng H; The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, China.
  • Sun D; Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing, China.
Front Oncol ; 12: 1055126, 2022.
Article en En | MEDLINE | ID: mdl-36591497

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza